About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,342 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,342 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 781-800 of 3,342 trials

CompletedTemozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaRATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT01005472·Los Angeles, California CompletedIpilimumab and Imatinib Mesylate in Advanced CancerThis phase I trial studies the side effects and best dose of ipilimumab and imatinib mesylate in treating patients with solid tumors that have spread to other places in the body…NCT01738139·Houston, Texas Active not recruitingBasket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor an NTRK1/2/3, ROS1, or ALK…NCT02568267·Phoenix, Arizona and 119 others

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

Active not recruitingQUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsQUILT-3.055 is a Phase 2b, open-label, multicohort study investigating combination immunotherapies in patients with advanced solid tumors who have previously been treated with…NCT03228667·Anchorage, Alaska and 34 others

CompletedIntratumoral Injections of LL37 for MelanomaThe goal of this clinical research study is to find the appropriate dose of LL37 that can be given to patients with melanoma.NCT02225366·Houston, Texas

RecruitingOH2 Injection in MelanomaTo evaluate the efficacy of OH2 injection in patients with unresectable or metastatic melanoma who have failed at least second-line standard therapy, using investigator-selected…NCT05868707·Beijing, Beijing Municipality and 29 others

CompletedAutologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV MelanomaThe CTLA-4 blocking monoclonal antibody ipilimumab (MDX-010, BMS-734016), has demonstrated anti-tumor activity in a subgroup of patients with Stage III (unresectable) or Stage IV…NCT01302496·Jette, Brabant

UnknownIdentification of Olfactory Biomarkers of Skin Cancer From Skin Odor Samples: a Pilot StudyThe aim of this research is to determine which volatile organic compounds (odors) are associated with different skin cancers.NCT06493786

TerminatedTrial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant MelanomaThe purpose of this study is to determine if treatment with the autologous cellular vaccine, Melaxin, in combination with Bacillus Calmette-Guerin (BCG) injections is effective in…NCT00671554·Greenville, South Carolina

UnknownVaccine Therapy in Treating Patients With Metastatic MelanomaRATIONALE: Vaccines may make the body build an immune response to kill tumor cells.NCT00022568·New York, New York

CompletedSafety Study of a Helper Peptide Vaccine Plus PembrolizumabThis study evaluates whether it is safe to administer a peptide vaccine in combination with pembrolizumab.NCT02515227·Charlottesville, Virginia

CompletedA Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV MelanomaThe purpose of this clinical research study is to evaluate the Best Overall Response Rate (BORR), (as per modified WHO criteria) in patients with previously treated melanoma-Stage…NCT00289627·Little Rock, Arkansas and 52 others

UnknownVaccine Therapy in Treating Patients With Metastatic MelanomaRATIONALE: Vaccines may make the body build an immune response to kill melanoma cells.NCT00002817·Philadelphia, Pennsylvania

CompletedDasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By SurgeryRATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00700882·Little Rock, Arkansas and 152 others

CompletedmRNA Electroporated Autologous Dendritic Cells for Stage III/IV MelanomaThis is an open label, 2-arm, 1-stage, randomized controlled phase II study in patients with AJCC stage IIIB/C \& -IV melanoma.NCT01676779·Brussels

UnknownDose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of escalating doses of RMC-4630 monotherapy in adult…NCT03634982·Scottsdale, Arizona and 11 others

RecruitingIL-17 Blockade to Decrease irAEs (REPLAY)The primary objective of this study is to determine the safety and feasibility of administering an IL-17A (human IgG1κ) monoclonal antibody, (Secukinumab, Cosentyx®) to…NCT07237594·Durham, North Carolina

CompletedAdenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells MaturedRATIONALE: Vaccines made from gene-modified tumor cells may help the body build an immune response to kill tumor cells.NCT00798629·Tampa, Florida

CompletedAn Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant MelanomaThis research study involves the use of two investigational drugs: sorafenib and bortezomib.NCT01078961·Boston, Massachusetts and 2 others

RecruitingNicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal TrialAs patients live longer after receiving an organ transplant, there is a need to reduce the long-term side effects of the drugs used to prevent organ rejection.NCT05955924·Calgary, Alberta and 6 others

PreviousPage 40 of 168Next